Clinical Study of XPO-1 Inhibitors Plus CAR-T Cells in Relapsed Refractory B-cell Non-Hodgkin's Lymphoma
Status:
Recruiting
Trial end date:
2024-02-10
Target enrollment:
Participant gender:
Summary
Aim of this study will evaluate the Efficacy and Safety of XPO-1 inhibitors in combination
with CAR-T cells in relapsed refractory B-cell non-Hodgkin's lymphoma
Phase:
Phase 2
Details
Lead Sponsor:
The First Affiliated Hospital of Soochow University